TXG position history
The shares of 10X Genomics (TXG) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 3,101,951 shares, $452M, 1.1% of portfolio
- 2021 Q4: 2,660,866 shares, $396M, 1.2% of portfolio, Reduce −14.2%
- 2022 Q1: 3,391,338 shares, $258M, 1.1% of portfolio, Add +27.5%
- 2022 Q2: 3,603,286 shares, $184M, 1.1% of portfolio, Add +6.2%
- 2022 Q3: 4,576,814 shares, $130M, 0.91% of portfolio, Add +27.0%
- 2022 Q4: 4,316,567 shares, $157M, 1.4% of portfolio, Reduce −5.7%
- 2023 Q1: 4,155,323 shares, $232M, 1.6% of portfolio, Reduce −3.7%
- 2023 Q2: 3,113,549 shares, $174M, 1.2% of portfolio, Reduce −25.1%
- 2023 Q3: 2,993,460 shares, $123M, 0.94% of portfolio, Reduce −3.9%
- 2023 Q4: 4,041,287 shares, $226M, 1.3% of portfolio, Add +35.0%
- 2024 Q1: 6,283,812 shares, $236M, 1.6% of portfolio, Add +55.5%
- 2024 Q2: 9,313,763 shares, $181M, 1.6% of portfolio, Add +48.2%
- 2024 Q3: 10,750,345 shares, $243M, 2.2% of portfolio, Add +15.4%
- 2024 Q4: 11,944,057 shares, $172M, 1.4% of portfolio, Add +11.1%
- 2025 Q1: 12,845,713 shares, $112M, 1.1% of portfolio, Add +7.5%
- 2025 Q2: 13,892,103 shares, $161M, 1.2% of portfolio, Add +8.1%
- 2025 Q3: 11,887,396 shares, $139M, 0.83% of portfolio, Reduce −14.4%
- 2025 Q4: 12,667,369 shares, $207M, 1.4% of portfolio, Add +6.6%
- 2026 Q1: 11,717,317 shares, $249M, 1.9% of portfolio, Reduce −7.5%
- 2026 Q2: 10,003,057 shares, $384M, 2.5% of portfolio, Reduce −14.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|